391 related articles for article (PubMed ID: 34327818)
1. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway.
Ying H; Fang M; Hang QQ; Chen Y; Qian X; Chen M
J Cell Mol Med; 2021 Sep; 25(18):8662-8675. PubMed ID: 34327818
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway.
Li N; Hang W; Shu H; Zhou N
J Cell Mol Med; 2022 Aug; 26(16):4548-4555. PubMed ID: 35861038
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
8. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
9. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J
J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450
[TBL] [Abstract][Full Text] [Related]
10. CpG-oligodeoxynucleotides may be effective for preventing ionizing radiation induced pulmonary fibrosis.
Zhang C; Zhao H; Li BL; Fu-Gao ; Liu H; Cai JM; Zheng M
Toxicol Lett; 2018 Aug; 292():181-189. PubMed ID: 29679710
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme 2 Inhibits Lipopolysaccharide-Caused Lung Fibrosis via Downregulating the Transforming Growth Factor
Lin X; Lin W; Zhuang Y; Gao F
J Pharmacol Exp Ther; 2022 Jun; 381(3):236-246. PubMed ID: 35347063
[TBL] [Abstract][Full Text] [Related]
12. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
Ma Z; Zhao C; Chen Q; Yu C; Zhang H; Zhang Z; Huang W; Shen Z
Pulm Pharmacol Ther; 2018 Dec; 53():100-106. PubMed ID: 30394340
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic Agent Pirfenidone Protects against Development of Radiation-Induced Pulmonary Fibrosis in a Murine Model.
Qin W; Liu B; Yi M; Li L; Tang Y; Wu B; Yuan X
Radiat Res; 2018 Oct; 190(4):396-403. PubMed ID: 30016220
[TBL] [Abstract][Full Text] [Related]
16. The Preventive Effect of Endostar on Radiation-induced Pulmonary Fibrosis.
Ying H; Zhou C; Hang Q; Fang M
Curr Mol Med; 2024; 24(5):610-619. PubMed ID: 37038709
[TBL] [Abstract][Full Text] [Related]
17. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
18. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of melatonin entrapped PLGA nanoparticles on radiation-induced lung injury through the miR-21/TGF-β1/Smad3 pathway.
Wang S; Li J; He Y; Ran Y; Lu B; Gao J; Shu C; Li J; Zhao Y; Zhang X; Hao Y
Int J Pharm; 2021 Jun; 602():120584. PubMed ID: 33887395
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis.
Lu X; Zhu C; Gao Y; Yu Z; Yan Q; Liu Y; Luo M; Shi X
Bioorg Chem; 2024 Feb; 143():107018. PubMed ID: 38071874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
